MD Magazine: Condition Center: Multiple Sclerosis Copyright (c) 2017 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/conditions/multiple-sclerosis-resources/rss Multiple Sclerosis en-us Tue, 17 Jul 2018 07:57:53 +0000 Ocrelizumab Delays Wheelchair Need by 7 Years for Patients with Progressive MS http://www.mdmag.com/medical-news/ocrelizumab-delays-wheelchair-need-by-7-years-for-patients-with-progressive-ms http://www.mdmag.com/medical-news/ocrelizumab-delays-wheelchair-need-by-7-years-for-patients-with-progressive-ms Thu, 14 Jun 2018 13:40:00 +0000 From Phase 1 to FDA Approval: Following a Drug Through the Development Pipeline http://www.mdmag.com/medical-news/from-phase-1-to-fda-approval-following-a-drug-through-the-development-pipeline http://www.mdmag.com/medical-news/from-phase-1-to-fda-approval-following-a-drug-through-the-development-pipeline Thu, 07 Jun 2018 11:00:00 +0000 FDA Approves First Multiple Sclerosis Therapy for Children http://www.mdmag.com/medical-news/fda-approves-first-multiple-sclerosis-therapy-for-children http://www.mdmag.com/medical-news/fda-approves-first-multiple-sclerosis-therapy-for-children Fri, 11 May 2018 20:54:00 +0000 Paulo Fontoura, MD, PhD: Ocrelizumab, Advanced Measures for PPMS http://www.mdmag.com/conference-coverage/aan-2018/paulo-fontoura-md-phd-ocrelizumab-advanced-measures-for-ppms http://www.mdmag.com/conference-coverage/aan-2018/paulo-fontoura-md-phd-ocrelizumab-advanced-measures-for-ppms Wed, 02 May 2018 09:00:00 +0000 Rick Rudick, MD: Progressing Collaborative, Evidence-Based MS Care http://www.mdmag.com/conference-coverage/aan-2018/rick-rudick-md-progressing-collaborative-evidencebased-ms-care http://www.mdmag.com/conference-coverage/aan-2018/rick-rudick-md-progressing-collaborative-evidencebased-ms-care Sat, 28 Apr 2018 11:00:00 +0000 MDNN: Acetaminophen Linked to ADHD, ASD, New DMT Recommendations for MS, and Resources for Managing Burnout http://www.mdmag.com/news-network/mdnn-acetaminophen-linked-to-adhd-asd-new-dmt-recommendations-for-ms-and-resources-for-managing-burnout http://www.mdmag.com/news-network/mdnn-acetaminophen-linked-to-adhd-asd-new-dmt-recommendations-for-ms-and-resources-for-managing-burnout Fri, 27 Apr 2018 19:03:00 +0000 Teriflunomide Therapy Switch Improves Patient Satisfaction in Relapsing MS http://www.mdmag.com/conference-coverage/aan-2018/teriflunomide-therapy-switch-improves-patient-satisfaction-in-relapsing-ms http://www.mdmag.com/conference-coverage/aan-2018/teriflunomide-therapy-switch-improves-patient-satisfaction-in-relapsing-ms Thu, 26 Apr 2018 01:34:00 +0000 AAN Emphasizes Patient Perspective, Transparency in MS Guideline Development http://www.mdmag.com/conference-coverage/aan-2018/aan-emphasizes-patient-perspective-transparency-in-ms-guideline-development http://www.mdmag.com/conference-coverage/aan-2018/aan-emphasizes-patient-perspective-transparency-in-ms-guideline-development Tue, 24 Apr 2018 14:00:00 +0000 New MS Guideline Addresses Starting, Switching, and Stopping Disease-modifying Therapy http://www.mdmag.com/conference-coverage/aan-2018/new-ms-guideline-addresses-starting-switching-and-stopping-diseasemodifying-therapy http://www.mdmag.com/conference-coverage/aan-2018/new-ms-guideline-addresses-starting-switching-and-stopping-diseasemodifying-therapy Mon, 23 Apr 2018 20:00:00 +0000 Ocrelizumab Succeeds in Open-label Extension of OPERA Trials http://www.mdmag.com/conference-coverage/aan-2018/ocrelizumab-succeeds-in-openlabel-extension-of-opera-trials http://www.mdmag.com/conference-coverage/aan-2018/ocrelizumab-succeeds-in-openlabel-extension-of-opera-trials Mon, 23 Apr 2018 12:00:00 +0000 Latino Patients with MS Struggle with Depression, Fewer Resources http://www.mdmag.com/conference-coverage/aan-2018/latino-patients-with-ms-struggle-with-depression-fewer-resources http://www.mdmag.com/conference-coverage/aan-2018/latino-patients-with-ms-struggle-with-depression-fewer-resources Mon, 23 Apr 2018 01:37:00 +0000 Siponimod Reduces Disability Progression, Cognitive Effects of SPMS http://www.mdmag.com/conference-coverage/aan-2018/siponimod-reduces-disability-progression-cognitive-effects-of-spms http://www.mdmag.com/conference-coverage/aan-2018/siponimod-reduces-disability-progression-cognitive-effects-of-spms Fri, 20 Apr 2018 11:39:00 +0000 James Stankiewicz, MD: The State of Multiple Sclerosis Treatment http://www.mdmag.com/medical-news/james-stankiewicz-md-the-state-of-multiple-sclerosis-treatment http://www.mdmag.com/medical-news/james-stankiewicz-md-the-state-of-multiple-sclerosis-treatment Sat, 14 Apr 2018 11:00:00 +0000 Are Some Risk Factors for Multiple Sclerosis Avoidable? http://www.mdmag.com/journals/md-magazine-neurology/2018/March-2018/are-some-risk-factors-for-multiple-sclerosis-avoidable http://www.mdmag.com/journals/md-magazine-neurology/2018/March-2018/are-some-risk-factors-for-multiple-sclerosis-avoidable Wed, 21 Mar 2018 14:45:00 +0000 Biogen, AbbVie Pull Daclizumab for Relapsing MS From Market http://www.mdmag.com/medical-news/biogen-abbvie-pull-daclizumab-for-relapsing-ms-from-market http://www.mdmag.com/medical-news/biogen-abbvie-pull-daclizumab-for-relapsing-ms-from-market Fri, 02 Mar 2018 22:22:00 +0000 FDA Sends Refusal to File Letter for Ozanimod http://www.mdmag.com/medical-news/fda-sends-refusal-to-file-letter-for-ozanimod http://www.mdmag.com/medical-news/fda-sends-refusal-to-file-letter-for-ozanimod Wed, 28 Feb 2018 21:09:00 +0000 FDA Approves Glatiramer Acetate Injection Generic for Relapsing MS http://www.mdmag.com/medical-news/fda-approves-glatiramer-acetate-injection-generic-for-relapsing-ms http://www.mdmag.com/medical-news/fda-approves-glatiramer-acetate-injection-generic-for-relapsing-ms Tue, 13 Feb 2018 15:02:00 +0000 Clinicians Practice Caution with Ocrelizumab's Approval http://www.mdmag.com/medical-news/clinicians-practice-caution-with-ocrelizumabs-approval http://www.mdmag.com/medical-news/clinicians-practice-caution-with-ocrelizumabs-approval Fri, 29 Dec 2017 12:00:00 +0000 MD Magazine's Most Watched Videos of 2017 http://www.mdmag.com/medical-news/md-magazines-most-watched-videos-of-2017 http://www.mdmag.com/medical-news/md-magazines-most-watched-videos-of-2017 Fri, 29 Dec 2017 10:00:00 +0000 Metabolite Taurine Boosts Oligodendrocyte Production in MS http://www.mdmag.com/medical-news/metabolite-taurine-boosts-oligodendrocyte-production-in-ms http://www.mdmag.com/medical-news/metabolite-taurine-boosts-oligodendrocyte-production-in-ms Wed, 20 Dec 2017 18:41:00 +0000 Multiple Sclerosis Treatment Adherence Correlates with Higher Care Costs http://www.mdmag.com/medical-news/multiple-sclerosis-treatment-adherence-correlates-with-higher-care-costs http://www.mdmag.com/medical-news/multiple-sclerosis-treatment-adherence-correlates-with-higher-care-costs Wed, 20 Dec 2017 18:00:00 +0000 Major Immune System Research Could Lead to MS Breakthroughs http://www.mdmag.com/medical-news/major-immune-system-research-could-lead-to-ms-breakthroughs http://www.mdmag.com/medical-news/major-immune-system-research-could-lead-to-ms-breakthroughs Tue, 19 Dec 2017 18:00:00 +0000 What Is Known and What Is Needed in Pediatric Multiple Sclerosis http://www.mdmag.com/journals/md-magazine-neurology/2017/December-2017/what-is-known-and-what-is-needed-in-pediatric-multiple-sclerosis http://www.mdmag.com/journals/md-magazine-neurology/2017/December-2017/what-is-known-and-what-is-needed-in-pediatric-multiple-sclerosis Tue, 19 Dec 2017 17:49:50 +0000 FDA Grants Breakthrough Designation to Fingolimod (Gilenya, Novartis) http://www.mdmag.com/medical-news/fda-grants-breakthrough-designation-to-fingolimod-gilenya-novartis http://www.mdmag.com/medical-news/fda-grants-breakthrough-designation-to-fingolimod-gilenya-novartis Mon, 18 Dec 2017 20:40:00 +0000 Martin Weber: Unmet Needs in MS and What We've Learned from NFL http://www.mdmag.com/post-conference-perspectives/ms-paris-2017-conference/martin-weber-unmet-needs-in-ms-and-what-weve-learned-from-nfl http://www.mdmag.com/post-conference-perspectives/ms-paris-2017-conference/martin-weber-unmet-needs-in-ms-and-what-weve-learned-from-nfl Sun, 17 Dec 2017 10:00:00 +0000 Francisco Quintana: The Need for New Candidate Therapies for MS http://www.mdmag.com/post-conference-perspectives/ms-paris-2017-conference/francisco-quintana-md-the-need-for-new-candidate-therapies-for-ms http://www.mdmag.com/post-conference-perspectives/ms-paris-2017-conference/francisco-quintana-md-the-need-for-new-candidate-therapies-for-ms Sat, 16 Dec 2017 10:00:00 +0000 Study: Two Molecules Speed Up Cell Reprogramming http://www.mdmag.com/medical-news/study-two-molecules-speed-up-cell-reprogramming http://www.mdmag.com/medical-news/study-two-molecules-speed-up-cell-reprogramming Wed, 13 Dec 2017 16:00:00 +0000 Do Disease-Modifying Therapies for MS Increase Risk of Infection? http://www.mdmag.com/medical-news/do-diseasemodifying-therapies-for-ms-increase-risk-of-infection http://www.mdmag.com/medical-news/do-diseasemodifying-therapies-for-ms-increase-risk-of-infection Wed, 13 Dec 2017 12:00:00 +0000 Blood Test Could Predict RRMS Disease Activity http://www.mdmag.com/medical-news/blood-test-could-predict-rrms-disease-activity http://www.mdmag.com/medical-news/blood-test-could-predict-rrms-disease-activity Mon, 11 Dec 2017 14:00:00 +0000 Study: Vaccines Not Associated with Onset of MS http://www.mdmag.com/medical-news/study-vaccines-not-associated-with-onset-of-ms http://www.mdmag.com/medical-news/study-vaccines-not-associated-with-onset-of-ms Mon, 11 Dec 2017 12:00:00 +0000